Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The study is being conducted to evaluate the efficacy, safety and tolerability of chemotherapy and apatinib with or without camrelizumab in the neoadjuvant (prior to surgery) or adjuvant (after surgery) treatment of previously untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma.
Epistemonikos ID: 6f4f2540682a7d16d4f36c8ed979ce7134f2df77
First added on: May 06, 2024